InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $3.72 million. The enterprise value is $1.21 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 1.21 million shares outstanding. The number of shares has increased by 154.47% in one year.
| Current Share Class | 1.21M |
| Shares Outstanding | 1.21M |
| Shares Change (YoY) | +154.47% |
| Shares Change (QoQ) | +13.94% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 6.74% |
| Float | 1.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.05 |
| Quick Ratio | 2.08 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.09 |
Financial Efficiency
Return on equity (ROE) is -83.50% and return on invested capital (ROIC) is -46.07%.
| Return on Equity (ROE) | -83.50% |
| Return on Assets (ROA) | -40.86% |
| Return on Invested Capital (ROIC) | -46.07% |
| Return on Capital Employed (ROCE) | -115.71% |
| Revenue Per Employee | $371,693 |
| Profits Per Employee | -$608,725 |
| Employee Count | 13 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 3.38 |
Taxes
In the past 12 months, INM has paid $7,100 in taxes.
| Income Tax | 7,100 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.10% in the last 52 weeks. The beta is 0.55, so INM's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -41.10% |
| 50-Day Moving Average | 2.69 |
| 200-Day Moving Average | 4.20 |
| Relative Strength Index (RSI) | 63.13 |
| Average Volume (20 Days) | 53,117 |
Short Selling Information
The latest short interest is 43,541, so 3.61% of the outstanding shares have been sold short.
| Short Interest | 43,541 |
| Short Previous Month | 27,449 |
| Short % of Shares Out | 3.61% |
| Short % of Float | 3.88% |
| Short Ratio (days to cover) | 1.20 |
Income Statement
In the last 12 months, INM had revenue of $4.83 million and -$7.91 million in losses. Loss per share was -$13.88.
| Revenue | 4.83M |
| Gross Profit | 1.71M |
| Operating Income | -7.77M |
| Pretax Income | -6.07M |
| Net Income | -7.91M |
| EBITDA | -7.55M |
| EBIT | -7.77M |
| Loss Per Share | -$13.88 |
Full Income StatementBalance Sheet
The company has $3.46 million in cash and $948,959 in debt, giving a net cash position of $2.51 million or $2.08 per share.
| Cash & Cash Equivalents | 3.46M |
| Total Debt | 948,959 |
| Net Cash | 2.51M |
| Net Cash Per Share | $2.08 |
| Equity (Book Value) | 6.18M |
| Book Value Per Share | 8.54 |
| Working Capital | 3.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.29 million and capital expenditures -$2, giving a free cash flow of -$7.29 million.
| Operating Cash Flow | -7.29M |
| Capital Expenditures | -2 |
| Free Cash Flow | -7.29M |
| FCF Per Share | -$6.04 |
Full Cash Flow StatementMargins
Gross margin is 35.39%, with operating and profit margins of -160.71% and -163.77%.
| Gross Margin | 35.39% |
| Operating Margin | -160.71% |
| Pretax Margin | -163.62% |
| Profit Margin | -163.77% |
| EBITDA Margin | -156.22% |
| EBIT Margin | -160.71% |
| FCF Margin | n/a |